Irrational Labs’ Post

The wait is over! Catch up on the March Lipedema Patient Roundtable, where special guest Nicholas Pennings, DO, FOMA, FACOFP, FAAFP fielded a host of insightful questions on the topic of GLP-1 medications and #lipedema, including side effects, insulin resistance, potential impacts on fibrosis, and more. 📺 Watch the replay here: https://loom.ly/wRfjLgM

💻 Missed our recent webinar? Now available on YouTube! Discover how the International Cholangiocarcinoma Patient Registry (ICPR) is helping accelerate research and supporting the patient community. This session provides key insights into how you can get involved in shaping the future of cholangiocarcinoma treatment. 🔗 Watch now https://lnkd.in/eA6ENiXV #Cholangiocarcinoma #PatientRegistry #CancerResearch #CureCCA #HealthcareInnovation

Patients are at the center 🎯 Important panel discussions are happening at the Deloitte NextGen Therapies Working Group Meetings as we connect the 🧩 puzzle pieces across the continuum to reach patients quickly. Let’s do this! #cellandgenetherapies #advancedtherapies #cellularimmunotherapies

MindPx™ is the first and only precision biomarker test that accurately predicts the most effective biologic class for psoriasis patients. This technology significantly increases the likelihood of achieving PASI 75 by week 4, marking a major advancement in personalized psoriasis care. By identifying the ideal biologic class for each patient, MindPx™ empowers healthcare professionals to make more informed treatment decisions that lead to better patient outcomes. #precisionmedicinerealized #mindpx #minderahealth

🚨 Exciting News in Healthcare Innovation! 🚨 MeMed has achieved FDA Breakthrough Device Designation (BDD) for its MeMed Severity test, a groundbreaking tool designed to support clinicians in managing suspected sepsis and acute infections. Leveraging advanced host-response technology and machine learning, MeMed Severity delivers actionable insights in under 15 minutes—helping predict severe outcomes within 72 hours or mortality risk within 14 days. Eran Eden, MeMed CEO, highlights: "This designation validates our commitment to equipping clinicians with valuable insights to improve care and save lives." Kudos to the team at MeMed and their partners, including Beckman Coulter Diagnostics, for transforming sepsis care! https://lnkd.in/e-2vriPk 📰 Stay ahead in healthcare by following Practical Patient Care on LinkedIn! Get the latest news and insights on patient care and clinical advancements. Join our community to stay informed and enhance your knowledge. Follow us today! #PracticalPatientCare #Innovation #Healthcare #SepsisManagement

In advanced breast #cancercare, particularly with new treatments like capivasertib, managing patient care can present unique challenges. NCODA’s PQI on Capivasertib Patient Management offers valuable insights into effectively integrating capivasertib into treatment strategies, addressing common concerns, and optimizing patient management. Discover how this resource can support patient care: https://bit.ly/3M6vdPD

🚨 Only a few days left to secure your spot for RIMS Webinar #19, happening virtually on Monday, October 28th at 4 PM! Don't miss out on this opportunity to gain valuable insights and discover more about the "Use of patient reported outcomes in persons with multiple sclerosis" ⬇️ Check out all the details below and register today! #RIMS #Webinar #MultipleSclerosis #Healthcare #PatientOutcomes #VirtualEvent #MedicalResearch

Identifying Unmet Patient Needs and Improving Outcomes Understanding the patient journey is critical to improving outcomes, and at Bridge Access Solutions, we’re making this easier than ever with the GLP-1 Patient Registry. Our registry enables pharma companies to: Identify adherence barriers and improve patient engagement strategies. *Map the full patient journey, uncovering gaps in care. *Analyze outcome metrics like weight loss, A1c reduction, and cardiovascular risk mitigation. *From regional disparities to demographic insights, we help you pinpoint opportunities to enhance treatment effectiveness and deliver better care. Ready to explore how this data can advance your patient engagement initiatives? Let’s talk! #BridgeAccessSolutions #PatientOutcomes #GLP1 #RealWorldEvidence #PharmaInnovation

📢 We are pleased to share that during the 𝗔𝗻𝗻𝘂𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗜𝘁𝗮𝗹𝗶𝗮𝗻 𝗠𝗦 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 (AISM ) and 𝗶𝘁𝘀 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻, an important session dedicated to the PROMS Initiative was held. This event, titled “𝗕𝗿𝗮𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵: 𝗥𝗲𝘁𝗵𝗶𝗻𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗼𝗳 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗦𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗥𝗲𝗹𝗮𝘁𝗲𝗱 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀,” provided a valuable opportunity for engagement and discussion among PROMS members.   The session, “𝗧𝗵𝗲 𝗥𝗼𝗹𝗲 𝗼𝗳 𝗣𝗮𝘁𝗶𝗲𝗻𝘁-𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗲𝗱 𝗗𝗮𝘁𝗮,” explored how patient-generated data is revolutionizing our understanding of #𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲𝘀𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀 and enhancing patient care. We had the privilege of hearing insightful presentations from esteemed experts, including Xavier Montalban, Mario Alberto Battaglia, Daniel Ontaneda, Helga Weiland, Giampaolo Brichetto, Giancarlo Comi, and Florian von Raison, MD. The concluding discussion, “𝗧𝗵𝗲 𝗣𝗮𝘁𝗵 𝗙𝗼𝗿𝘄𝗮𝗿𝗱 𝘁𝗼 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗔𝗴𝗲𝗻𝗱𝗮 𝗮𝗻𝗱 𝗙𝘂𝗿𝘁𝗵𝗲𝗿 𝗦𝘁𝗮𝗸𝗲𝗵𝗼𝗹𝗱𝗲𝗿𝘀’ 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻,” was skillfully led by Tim Coetzee and Paola Zaratin.   For those who could not attend in person, the complete presentations, including slides, are now available for review. You can watch the recorded sessions and access the slides at the following link ➡ https://lnkd.in/ep-GMu7a (from 4:32:00 to 7:10:00)   This session was an invaluable moment for sharing insights and advancing our collective efforts in multiple sclerosis research and patient care. We look forward to continued collaboration and innovation as we explore new horizons in understanding and diagnosing multiple sclerosis.   #MultipleSclerosis #MSResearch #PatientCare #DigitalHealth #PROMS #HealthcareInnovation #ClinicalResearch

Thrilled to be leading this important discussion on the complexity of the healthcare system and how a doctor-led approach simplifies the experience and drives better health outcomes. Healthcare is becoming increasingly complicated and conditions like Cancer, MSK, and Cardiovascular Disease continue to drive significant cost for employees and employers alike. When you put world class doctors at the forefront of guiding care, we unlock a more effective and efficient experience for patients and providers. I'll be diving into this topic on Shortlister on October 23rd. I can't wait to explore how SUMMUS' innovative, physician-led model is transforming the healthcare landscape and driving lower medical costs for employers and employees. #SUMMUS #ClinicalNavigation #EndtoEndPrograms #Healthcare